Initial government funded research and development work in cardiac-support systems in 1966. The company began clinical trials of the air-driven LVAS in 1986 and of the electric system in 1991. It has been used in patients ranging from age 11 to 78, with an average age of 51. The HeartMate device has been implanted in more than 4,100 patients at leading cardiac centers in the U.S. and overseas.

No. The HeartMate is available to any qualified hospital that performs open-heart surgery. There are approximately 900 such centers in the United States. Implanting the device at non-transplant centers increases the likelihood that patients will be in a familiar environment, close to friends and family during their hospital stay, and close to their doctors once they return home.

No. The HeartMate systems are available to any qualified hospital that performs open-heart surgery. There are approximately 900 such centers in the United States. Implanting the device at non-transplant centers increases the likelihood that patients will be in a familiar environment, close to friends and family during their hospital stay, and close to their doctors once they return home.

More than 30 years in development, the HeartMate LVAS is a blood pump that, when implanted alongside the natural heart, takes over part of the heart's pumping function. The HeartMate LVAS is designed to assist the left ventricle, (the main chamber that performs 80 percent of the heart's work), which is responsible for pumping oxygen-rich blood from the lungs throughout the body.

RENOVA should only be used under medical supervision as part of a total skin care and sun protection program. It should not be used by individuals with a history of sensitivity reactions to any of its components, and should be discontinued if hypersensitivity to any of its ingredients is noted. RENOVA should not be used by people taking drugs known to be photosensitizers, or by pregnant women, women attempting to become pregnant or in women at high risk of pregnancy.

Yes. CoagCare offers secure access from anywhere with internet access. We have even had patients who communicated with their physician while on a cruise!

Every whole blood donation can help save up to three lives. This is accomplished because the donation is separated into three separate components:

Tissue is used in a wide range of vital medical procedures, including grafting skin for burn victims, replacing defective heart valves, saving limbs following tumor surgery, reconstructing hip and knee joints and enhancing spinal fusion.

The HeartMate LVAS is designed to assist the left ventricle (the main pumping chamber of the natural heart), which is responsible for pumping oxygen-rich blood from the lungs throughout the body. The system is used in patients with advanced heart failure to support the left ventricle, which performs 80 percent of the heart's work. The central component of the HeartMate LVAS, the implantable blood pump, is placed just below the diaphragm in the abdomen.

Patients scheduled for an endoscopic discectomy are requested to stay in California for three days. They will be seen for a consultation and surgery discussion on the first day, surgery will be performed on the second day, and they can return home on the third day after a post-operative visit with the doctor. Patients with open discectomies are requested to stay for at least two days post-operatively.

The longest study was 6 months. As long as patients continue the treatment, using the device routinely, the benefits in lowering blood pressure are maintained. There are people who have been using RESPeRATE for over five years and continue to maintain normal BP. In all clinical trials, blood pressure values were measured as next morning results and not directly after the intervention. A sustained, all-day reduction has been showed in a 24-hours ambulatory study.

Menus: All · A · B · C · D · E · F · G · H · I · J · K · L · M · N · O · PQ · R · S · T · UV · WXYZ

If the patient has a caregiver (nurse, children, friend) who can access the Internet, the caregiver can input patient data for them. The caregiver will then be responsible for making sure the patient receives any new dose or testing frequency changes, as well as pass along any personalized messages from the healthcare provider. We have had several patients use this approach, with great success!

The MoleMapCD is an excellent tool for regular, at-home, Skin Self-Examinations (SSE). Patients at high risk of melanoma should use the CD when checking their skin for any changes. The MoleMapCD Patient Brochure contains information on using the MoleMapCD during a SSE as well as a log to record SSE dates [Patient Brochure]. If a patient sees something suspicious, they should print out the screen and circle the troubling area.

Tarceva is indicated for the treatment of patients with locally advanced or metastatic Non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen. In the pivotal clinical trial for NSCLC, there was a significant survival benefit for a large, unselected group of patients receiving Tarceva monotherapy. Tarceva significantly improved overall survival by 37% vs placebo in these pretreated NSCLC patients (HR=0.73; 95% CI=0.61-0.86; P<0.001).

Yes, we have a Professional Dispensing program that enables you to provide RESPeRATE to your clients -- directly from your clinic. You can choose to loan or rent RESPeRATE to your clients or sell it to them. At the same time, the program fairly compensates you for your time. Please note that the best way for a patient to lower their blood pressure (BP) and sustain that blood pressure is to use it routinely at home. Yes.

Yes and no. Each laser has different wavelengths and power levels that can be used safely during different periodontal procedures. However, damage to periodontal tissues can result if an inappropriate wavelength and/or power level is used during a periodontal procedure. this time, there is insufficient evidence to suggest that any specific laser wavelength is superior to the traditional treatment methods of the common periodontal diseases, such as periodontitis.

The HeartMate LVAS incorporates several advances in biological compatibility that distinguish it from other cardiac-assist devices, including proprietary textured blood-contacting surfaces that are designed to significantly reduce the likelihood of blood clots, which can lead to stroke and death. As blood enters the pump chamber, blood elements are trapped by the textured surface and form a lining similar to that found in arteries and veins.

Since the Orthotrac Pneumatic Vest is a symptom relieving tool, the patient usually wears the device while they are performing some type of weight-bearing activity that normally produces or worsens his/her symptoms. This may be for a time as short as 30 minutes or as long as a number of hours.

The company has been operating for over 15 years. We have over 100 clinics, including the U.S., Latin America, Europe, and the Middle East..

Interview software takes longer than a physician would to gain the same information. If you normally take 5 minutes to gather the patient’s history, Instant Medical History™ will require 10 minutes. The average interview takes less than 10 minutes, but keep in mind that patient entered data is free. It is patient time instead of physician time. A valuable implementation of Instant Medical History™ is on a physician’s web site.

The Orthotrac allows patients to return to work and to the lifestyle they once enjoyed before the onset of debilitating back pain. In a recent study of over 300 patients, more than 70% realized significant functional improvement along with a significant decrease in reported pain, averaging 28%. It has been demonstrated that the Orthotrac Pneumatic Vest improves the activities of daily living, while reducing pain, in patients with low back pain and/or radiating leg pain.

The BiPAP® autoSV™ is designed to treat complicated breathing patterns in sleep patients. Nevertheless, utilizing the 3 different pressure settings and a standard backup rate of 4 -30bpm, the device can be set similar to that of a standard S/T device. The ASV algorithm is not able to assure a volume which would be most beneficial for these types of patients.

Medical condition is not caused by a motor vehicle accident covered by insurance or a work related illness or injury that involves Workers' Compensation coverage.

It is expected to take about 18 months to recruit all the study subjects, from November 2001 to May 2003.

Many factors contribute to lengthy waiting times in Canada. According to health care professionals these include: chronic disease among Canadians (83 per cent); a shortage of health care professionals (83 per cent) and hospital beds or medical equipment (74 per cent); and, inadequate funding for Canada's health care system (72 per cent).4

New patients first fill out a questionnaire of past medical history, their present symptoms, and all the medications they’re currently taking. They are then interviewed by a nurse who obtains a detailed history of their symptoms and information about their environment. Depending on their medical condition, patients then receive specialized testing for allergies or lung function, if needed, followed by an evaluation by Dr. Jain.

The Hospice does not offer ???long stay??? admissions. Patients are here as long as they need specialist care; as a guide the average length of stay is 11 days.

Only 11% of our work takes place in the in-patient unit with the majority taking place either in patients own homes or at our day hospices or clinics. The average length of stay in the in-patient unit is 9 days with 66% of our patients returning home or into nursing care after their stay.